ReviewCurrent diabetes reports2026
Mobile Health Interventions to Support Self-Management in Youth with Type 1 Diabetes.
Review in Current diabetes reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purpose of reviewYouth with type 1 diabetes face demanding daily self-management requirements. Mobile health interventions are a promising approach for supporting diabetes self-management both within clinical care and in everyday contexts. This review synthesizes recent evidence published between 2018 and 2024 on mobile health interventions designed to support self-management in children and adolescents with type 1 diabetes. RECENT
findingsForty-four studies met inclusion criteria. Most were early-phase evaluations emphasizing feasibility, usability, and engagement. Across modalities, mHealth interventions were most successful at lowering hemoglobin A1c when they provided real-time, actionable support during insulin dosing or carbohydrate estimation. Engagement trajectory emerged as an important determinant of clinical benefit, suggesting that initial usability alone are insufficient to produce meaningful clinical impact. Mobile health interventions for youth with type 1 diabetes are feasible, acceptable, and effective for improving self-management processes and psychosocial outcomes. Glycemic improvements occur selectively when interventions provide point-of-need decision support and when engagement is sustained. Future research should prioritize mechanisms of action, strategies to support long-term engagement, and rigorous effectiveness-implementation trials to support scalable clinical impact.
Indexed as
Identifiers
42789162What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.